In Silico Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 Diabetes

Schiavon, M; Visentin, R; Giegerich, C; Sieber, J; Dalla Man, C; Cobelli, C; Klabunde, T

Klabunde, T (corresponding author), Sanofi Aventis Deutschland GmbH, Translat Dis Modeling, R&D Digital & Data Sci, Ind Pk Hochst, D-65926 Frankfurt, Germany.

DIABETES TECHNOLOGY & THERAPEUTICS, 2020; 22 (8): 553

Abstract

Background: Second-generation long-acting insulin glargine 300 U/mL (Gla-300) and degludec 100 U/mL (Deg-100) provide novel basal insulin therapies fo......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索